[PubMed | ClinicalTrials.gov | DOI] Wadden TA, Bailey TS, Billings LK, et al
Supplementary information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made
doi:10.1016/j.fertnstert.2013.08.032
Its phase 3 trial showing efficacy there, not where the primary outcome is the improvement of the complication
Key Product Information Format Solid research material Presentation 5 mg research vial Documentation COA available where applicable Supplier UK-based D&L Peptides dispatch What Is SLU-PP-332